ProNephro AKI (NGAL) is now FDA-Cleared     READ MORE

Investor Meetings & Events

Annual General Meeting

April 11, 2025

The Annual General Meeting (AGM) is scheduled for April 11, 2025.

Additional details including the notice convening the AGM, agenda, and other relevant information will be made available closer to the meeting date.

Investor Event

September 24, 2025 | 14:00-18:00

Mød Selskabet Live i Fredericia

Hosted by Dansk Aktionærforening

Extraordinary General Meeting

November 23, 2022

BioPorto’s Extraordinary General Meeting will be held on November 23, 2022, 9.00 am (CET) at the Company’s address, Tuborg Havnevej 15, st. 2900 Hellerup, Denmark.

Questions concerning the EGM?
EMAIL US

Notice convening the EGM including the agenda and information on share capital and voting rights.
DOWNLOAD

Total number of shares and voting rights
DOWNLOAD

Request for admission card. Due no later than November 18, 2022.
DOWNLOAD

 

Proxy and vote by correspondence form. Due no later than November 18, 2022.
DOWNLOAD

Investor Event

October 7, 2025 | 17:00-19:00

The Auditorium
Tuborg Havnevej 15, st.
2900 Hellerup

Market Trends in Nordic Healthcare Equities

Hosted by BioPorto & Ascelia Pharma

Invitation & Agenda – DK

Please register to confirm your attendance no later than October 1, 2025.

Q3 2025 Earnings Report

November 19, 2025

Online Investor Presentation

13:00 CEST
via HC Andersen Capital